Compare Eli Lilly And Co (LLY) vs Unity Software Inc (U) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Eli Lilly And Co vs Unity Software Inc — how do they compare? Eli Lilly And Co trades at $1,179.27 (market cap $1.04T), while Unity Software Inc trades at $46.88 (market cap $20.20B). The key difference: Eli Lilly And Co is far larger — about 51.5× Unity Software Inc's market cap, and Eli Lilly And Co pays a 0.59% dividend while Unity Software Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 93 Days and Unity Software Inc for 50 Days on average.
| LLY | U | |
|---|---|---|
Market Cap | $1.04T | $20.20B |
Volume | 3,064,878 | 15,432,191 |
Sector | Health | Technology |
52-Week High | $1.28K | $49.47 |
52-Week Low | $799.57 | $17.13 |
Typical Hold Time | 93 Days | 50 Days |
Enterprise Value | $1.09T | $20.08B |
Dividend Yield | 0.59% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,169.93, down 1.58% on the day, but maintains strong bullish momentum with consistent earnings beats and robust revenue growth. The company demonstrates exceptional profitability with 83.4% gross margins and 33.53% net income margins, supported by dominant positioning in weight-loss and diabetes treatments. Recent clinical trial successes for next-generation drugs and expanded FDA approvals reinforce growth prospects.
LLY presents compelling growth potential with analyst consensus target of $1,350 representing 15% upside, though elevated valuations (P/E 39.26) and increasing competition in obesity drugs pose risks. Strong institutional support (73% buy ratings) and positive pipeline developments support continued momentum, but investors should monitor execution risks and market saturation concerns.
Unity Software (U) trades at $45.89, up 0.99% today, with strong analyst support (83% buy ratings) and a $46.54 consensus price target. Recent momentum is fueled by Meta VR partnership news and positive technical signals, though the stock faces fundamental challenges with negative profitability metrics and consecutive earnings misses. Cash flow trends show improvement with 2025 operating cash flow reaching $423 million.
The stock presents a growth opportunity with accelerating strategic revenue and AI platform transformation, but carries significant risk from persistent losses and high valuation multiples. Investors must weigh strong institutional support against ongoing profitability challenges and competitive pressures in the gaming engine market.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →About Unity Software Inc
Unity Software Inc provides a software platform for creating and operating interactive, real-time 3D content. The platform can be used to create, run and monetize interactive, real-time 2D and 3D content for mobile phones, tablets, PCs, consoles, and augmented and virtual reality devices. The business is spread across the United States, Greater China, EMEA, APAC and Other Americas, of which key revenue is derived from the EMEA region. The products are used in the gaming industry, architecture and construction sector, animation industry, and designing sector.
Read more on U →
